These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 33016802)

  • 41. Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn's disease.
    Ardizzone S; Maconi G; Sampietro GM; Russo A; Radice E; Colombo E; Imbesi V; Molteni M; Danelli PG; Taschieri AM; Bianchi Porro G
    Gastroenterology; 2004 Sep; 127(3):730-40. PubMed ID: 15362028
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylaxis of postoperative relapse in Crohn's disease with mesalamine: European Cooperative Crohn's Disease Study VI.
    Lochs H; Mayer M; Fleig WE; Mortensen PB; Bauer P; Genser D; Petritsch W; Raithel M; Hoffmann R; Gross V; Plauth M; Staun M; Nesje LB
    Gastroenterology; 2000 Feb; 118(2):264-73. PubMed ID: 10648454
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Steroid dependency and pediatric inflammatory bowel disease in the era of immunomodulators--a population-based study.
    Jakobsen C; Munkholm P; Paerregaard A; Wewer V
    Inflamm Bowel Dis; 2011 Aug; 17(8):1731-40. PubMed ID: 21744428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Creeping Fat Assessed by Small Bowel MRI Is Linked to Bowel Damage and Abdominal Surgery in Crohn's Disease.
    Althoff P; Schmiegel W; Lang G; Nicolas V; Brechmann T
    Dig Dis Sci; 2019 Jan; 64(1):204-212. PubMed ID: 30276568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Profile of pediatric Crohn's disease in Belgium.
    De Greef E; Mahachie John JM; Hoffman I; Smets F; Van Biervliet S; Scaillon M; Hauser B; Paquot I; Alliet P; Arts W; Dewit O; Peeters H; Baert F; D'Haens G; Rahier JF; Etienne I; Bauraind O; Van Gossum A; Vermeire S; Fontaine F; Muls V; Louis E; Van de Mierop F; Coche JC; Van Steen K; Veereman G; ;
    J Crohns Colitis; 2013 Dec; 7(11):e588-98. PubMed ID: 23664896
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical recurrence in Crohn's disease: a comparison between different types of bowel resections.
    Aaltonen G; Carpelan-Holmström M; Keränen I; Lepistö A
    Int J Colorectal Dis; 2018 Apr; 33(4):473-477. PubMed ID: 29492657
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery.
    Cosnes J; Nion-Larmurier I; Beaugerie L; Afchain P; Tiret E; Gendre JP
    Gut; 2005 Feb; 54(2):237-41. PubMed ID: 15647188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colonoscopy-guided therapy for the prevention of post-operative recurrence of Crohn's disease.
    Candia R; Bravo-Soto GA; Monrroy H; Hernandez C; Nguyen GC
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012328. PubMed ID: 32746500
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Late-onset Crohn's disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease 'AGED' study.
    Viola A; Monterubbianesi R; Scalisi G; Furfaro F; Rea M; Saibeni S; Aratari A; Bringiotti R; Casella G; Cantoro L; Frankovic I; Calella F; Pugliese D; Orlando S; Samperi L; Cappello M; Mocci G; Manetti N; Annese V; Privitera AC; Inserra G; Caprioli F; D'Incà R; Principi M; Papi C; Castiglione F; Danese S; Ardizzone S; Bossa F; Kohn A; Manguso F; Alibrandi A; Fiorino G; Armuzzi A; Fries W;
    Eur J Gastroenterol Hepatol; 2019 Nov; 31(11):1361-1369. PubMed ID: 31567640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes of Crohn's disease phenotype over time.
    Ouaz A; Fekih M; Labidi A; Ben Mustapha N; Serghini M; Zouiten L; Boubaker J; Filali A
    Tunis Med; 2016 Jun; 94(6):167-170. PubMed ID: 28051217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Declining hospitalisation and surgical intervention rates in patients with Crohn's disease: a population-based cohort.
    Rahman A; Jairath V; Feagan BG; Khanna R; Shariff SZ; Allen BN; Jenkyn KB; Vinden C; Jeyarajah J; Mosli M; Benchimol E
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1086-1093. PubMed ID: 31621934
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term course of Crohn's disease in Japan: Incidence of complications, cumulative rate of initial surgery, and risk factors at diagnosis for initial surgery.
    Sato Y; Matsui T; Yano Y; Tsurumi K; Okado Y; Matsushima Y; Koga A; Takahashi H; Ninomiya K; Ono Y; Takatsu N; Beppu T; Nagahama T; Hisabe T; Takaki Y; Hirai F; Yao K; Higashi D; Futami K; Washio M
    J Gastroenterol Hepatol; 2015 Dec; 30(12):1713-9. PubMed ID: 26094852
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.
    Targownik LE; Benchimol EI; Bernstein CN; Singh H; Lix L; Tennakoon A; Leung S; Aviña A; Coward S; Jones J; Kaplan G; Murthy SK; Nguyen GC; Peña-Sánchez JN
    Clin Gastroenterol Hepatol; 2019 Aug; 17(9):1788-1798.e2. PubMed ID: 30448599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The gap between scientific evidence and clinical practice: 5-aminosalicylates are frequently used for the treatment of Crohn's disease.
    Schoepfer AM; Bortolotti M; Pittet V; Mottet C; Gonvers JJ; Reich O; Fournier N; Vader JP; Burnand B; Michetti P; Froehlich F
    Aliment Pharmacol Ther; 2014 Oct; 40(8):930-7. PubMed ID: 25146487
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Single-incision laparoscopic surgery for stricturing and penetrating Crohn's disease.
    Mizushima T; Nakajima K; Takeyama H; Naito A; Osawa H; Uemura M; Nishimura J; Hata T; Takemasa I; Yamamoto H; Doki Y; Mori M
    Surg Today; 2016 Feb; 46(2):203-8. PubMed ID: 25735739
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Has there been a change in the natural history of Crohn's disease? Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977-2009.
    Lakatos PL; Golovics PA; David G; Pandur T; Erdelyi Z; Horvath A; Mester G; Balogh M; Szipocs I; Molnar C; Komaromi E; Veres G; Lovasz BD; Szathmari M; Kiss LS; Lakatos L
    Am J Gastroenterol; 2012 Apr; 107(4):579-88. PubMed ID: 22233693
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical course of Crohn's disease in a Danish population-based inception cohort with more than 50 years of follow-up, 1962-2017.
    Burisch J; Lophaven S; Langholz E; Munkholm P
    Aliment Pharmacol Ther; 2022 Jan; 55(1):73-82. PubMed ID: 34543457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreasing major surgical rates for Crohn's disease in an emerging economy over two decades: Is it due to biologic therapy?
    Chuah KH; Raja Ali RA; Hilmi IN
    Indian J Gastroenterol; 2020 Jun; 39(3):261-267. PubMed ID: 32613522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A risk score system to timely manage treatment in Crohn's disease: a cohort study.
    Pallotta N; Vincoli G; Pezzotti P; Giovannone M; Gigliozzi A; Badiali D; Vernia P; Corazziari ES
    BMC Gastroenterol; 2018 Nov; 18(1):164. PubMed ID: 30400823
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.